Piramal Pharma Limited Announces Results for Q3 and 9M FY26

About this update from Piramal Pharma Limited

[{"type":"text","content":"MUMBAI, India, Jan. 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Third Quarter (Q3) and Nine Month (9M) ended 31st December 2025.","length":290,"tagName":"p"},{"type":"image","alt":"Piramal Pharma Limited Logo","displaySize":"","headline":null,"caption":"Piramal Pharma Limited Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":164,"url":"https://media.zenfs.com/en/cnwgroup.com/3682f34603da970e9bba37e7d4b7357f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NzbhtHVCyEgmMyQGam6sHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI4OTtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/3682f34603da970e9bba37e7d4b7357f","width":400,"height":164}}},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"7","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Consolidated Financial Highlights","length":33,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"7","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:RIGHT;","val":[{"type":"text","content":"(in ₹ Crores or as stated)","length":26,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Particulars","length":11,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:CENTER;","val":[{"type":"text","content":"Q3FY26","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Q3FY25","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"YoY %","length":5,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"9MFY26","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1...

More updates from Piramal Pharma Limited